Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial

Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:04:30.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page shows a new footer revision 'Revision: v3.4.2' and removes the government funding status notice (formerly 'Revision: v3.4.1'). This appears to be a routine site maintenance update with no effect on the study content or results.
    Difference
    0.4%
    Check dated 2026-02-11T05:07:20.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A global banner about government funding and NIH operations was added, with links to cc.nih.gov and opm.gov, and the site revision updated to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T03:45:52.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    UI and metadata updates: a glossary display option was added, and the study history now includes 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.
    Difference
    0.2%
    Check dated 2026-01-28T00:18:36.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.1%
    Check dated 2026-01-14T01:48:21.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Footer updates include the addition of Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T10:10:48.000Z thumbnail image

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.